Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Latent tuberculosis infection: old problem, new priorities

Kevin Schwartzman1

  • 1Respiratory Division, McGill University Health Centre, Montreal, Que. kevin.schwartzman@mcgill.ca

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|April 12, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Projected Effects of Changing Global Tuberculosis Epidemiology on Mycobacterium tuberculosis Immunoreactivity Prevalence, 2024-2050.

Emerging infectious diseases·2026
Same author

Cost evaluation of a multimodal prehabilitation program for high-risk lung cancer surgery.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Improving the tuberculosis infection care cascade among migrants in Canada: a cost-effectiveness modelling study.

The Lancet. Public health·2026
Same author

Moral distress among health care workers and decision-makers undermines tuberculosis infection screening and treatment programs for migrants in Canada: a reflexive thematic analysis.

BMC health services research·2025
Same author

Functional Outcomes, Lung health and Livelihood Outcomes among people With Tuberculosis (FOLLOW-TB): study protocol for a multicentre, prospective cohort study in Canada.

BMJ open·2025
Same author

The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study.

The Lancet. Global health·2025